The strangulation of Barry and Honey Sherman has set off talk of corporate intrigue and feuding cousins.
A leaked Colombian Embassy memo suggests the U.S. wants to preserve the high price of cancer drug Gleevec.
The drugs industry is the most profitable on earth. It has two branches -- an illegal one consisting of drug cartels and a legal one consisting of drug companies. The huge profits derived by both branches accrue from the same source -- monopoly price gouging.
In many ways, yes. But there are a few key differences you should know about.
The TPP and other trade agreements create an economic race to the bottom, creating a nation of Walmart shoppers rather than family wage jobs and an economically and environmentally sustainable future.
"Of these NTI drugs, patients with anti-epilepsy drugs are a unique group that do equally well when started on brand or generic
Also, once generic drugs are approved, there's greater competition, which drives the price down. Today, nearly 8 in 10 prescriptions
If the public interest is at the core of the FDA's mission, it needs to move quickly and promulgate rules that will facilitate market entry, heighten industry price competition, save consumers money, and produce better patient outcomes.
But regardless of occupation, survey respondents who knew all the active ingredients in a medication were 19 percent more
No matter how long some of the most onerous provisions are delayed, the TPP in its current form will be a terrible deal for all countries involved. Negotiating countries must not be fooled by this so-called compromise from U.S. negotiators.
Recently, Phil DeLuca, a retired Long Island Railroad worker, was profiled on a national news television program. Suffering from a potentially fatal red blood cell deficiency, he receives a weekly shot of Procrit. Simple enough, but that shot costs a staggering $1,500, of which his co-pay is $196.
Buried under fancy-sounding terms like Trade Related Intellectual Property Rights (TRIPS) and Special 301 is the real irony that availability of cheap drugs is not just a concern for the poor in an India or a China, but also for the poor back home in the US.
Clearly the goal of reducing the enormous cost burden of prescribed drugs is a legitimate one. If a drug that costs $200 a year is just as good as one that costs $2,000, restricting the latter makes sense. But the situation is not that simple.
What can you do to find affordable medications? Here is a long list of my tips.
Cancer and the common cold will still be with us. The difference is that nearly everyone will be able to get the care they need in either situation. That's a big step forward.
The issue of what patients want versus what physicians prescribe can sometimes leave pharmacists in the middle, said Jon
"There can't be a medical reason that so many more patients on Medicare need brand name drugs compared to those than at the VA."
The Obama administration and members of Congress are pressing India to curb its generic medication industry.